212. Jain S, Vaidyanathan B Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature. Ann Pediatr Cardiol 2010 Jan [cited 2021 Aug 20];3:31–4.
213. Alakeel YS, Jijeh AMZ, BinSabbar NS, Almeshary MF, Alabdan NA, Gramish JA, Al Essa MA. The impact of child-specific characteristics on warfarin dosing requirements. Res Pract Thromb Haemost. 2024 Jan 22;8(1):102321.
214. Prevention of thrombosis and embolism in children and adolescents with mechanical valve prostheses: warfarin versus antiplatelet agents - PubMed [cited 2021 Aug 20];Available from: https://pubmed.ncbi.nlm.nih.gov/16784079/
215. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AGG Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001 Jan 1;119:220S-227S.
216. Mok CK, Boey J, Wang R, Chan TK, Cheung KL, Lee PK, et al. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: A prospective randomized clinical trial. Circulation 1985;72:1059–1063.
217. Bradley LM, Midgley FM, Watson DC, Getson PR, Scott LP Anticoagulation therapy in children with mechanical prosthetic cardiac valves. Am J Cardiol 1985 Sep 15;56:533–535.
218. Jobs A, Stiermaier T, Klotz S, Eitel I Antiplatelet or anticoagulative strategies after surgical/interventional valve treatment. Herz 2018 Feb 1;43:26–33.
219. Harkin M, Shaddix B, Neely S, Peek L, Stephens K, Barker P, et al. Evaluation of dosing and safety outcomes of low-dose prophylactic warfarin in children after cardiothoracic surgery. Am J Health Syst Pharm 2020;77:1018–1025.
220. Monagle P, Chan A, Goldenberg N, Ichord R, Journeycake J, Nowak-Göttl U, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e737S-e801S.
221. Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012;141:e576S-e600S.
222. Cao H, Wu T, Chen W, Fu J, Xia X, Zhang J The effect of warfarin knowledge on anticoagulation control among patients with heart valve replacement. Int J Clin Pharm 2020 Jun 1;42:861–870.
223. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016 Jan 1;37:67–119.
224. Budts W, Pieles GE, Roos-Hesselink JW, De La Garza MS, D’Ascenzi F, Giannakoulas G, et al. Recommendations for participation in competitive sport in adolescent and adult athletes with Congenital Heart Disease (CHD): position statement of the Sports Cardiology & Exercise Section of the European Association of Preventive Cardiology (EAPC), the European Society of Cardiology (ESC) Working Group on Adult Congenital Heart Disease and the Sports Cardiology, Physical Activity and Prevention Working Group of the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2020 Nov 14;41:4191–4199.
225. Edraki M, Nobakhti M, Naghshzan A, Amoozgar H, Amirghofran A, Ghasemzadeh B, Nirooie E, Mehdizadegan N, Mohammadi H, Keshavarz K. Mitral and aortic valve regurgitation following surgical and transcatheter perimembranous ventricular septal defect closure in children and adolescents: midterm outcomes. BMC Cardiovasc Disord. 2022 Jul 15;22(1):315.
226. Johnson JT, Eckhauser AW, Pinto NM, Weng HY, Minich LL, Tani LY. Indications for intervention in asymptomatic children with chronic mitral regurgitation. Pediatr Cardiol. 2015 Feb;36(2):417-22. doi: 10.1007/s00246-014-1026-z. Epub 2014 Oct 11. PMID: 25304243.
227. Maschietto N, Prakash A, Del Nido P, Porras D. Acute and Short-Term Outcomes of Percutaneous Transcatheter Mitral Valve Replacement in Children. Circ Cardiovasc Interv. 2021 Apr;14(4):e009996. doi: 10.1161/CIRCINTERVENTIONS.120.009996. Epub 2021 Mar 16. PMID: 33722065.
228. Al Nasef M, Alsahari A, Eltayeb A, Ahmad S, Al Khalaf K, Al Otaiby M, Al Moghairi A, Al Khushail A, Al Amri H, Elmandouh D, Momenah T. Transcatheter Mitral Valve-in-Valve Implantation in Pediatric Patients. CJC Open. 2021 Aug 27;4(1):20-27. doi: 10.1016/j.cjco.2021.08.007. PMID: 35072024; PMCID: PMC8767141.
229. Baumgartner H., De Backer J., Babu-Narayan S.V. et al. 2020 ESC Guidelines for themanagement of adult congenital heart disease. The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC)//European Heart Journal (2020) 00, 1-83.
230. Mauritz G.J., Rizopoulos D., Groepenhoff H. et al. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension. Am J Cardiol. 2011. 108(11):1645-50.
231. Roberts E, Ludman AJ, Dworzynski K, Al-Mohammad A, Cowie MR, McMurray JJ, Mant J; NICE Guideline Development Group for Acute Heart Failure. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. BMJ. 2015 Mar 4;350:h910.
232. Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, Hardman SM, Dargie HJ, Cowie MR. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail. 2005 Jun;7(4):537-41.
233. Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, Johnston JI, Smellie WS, Duffy V, Cawley P. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract. 2006 May;56(526):327-33.